Zymeworks Inc (ZYME):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zymeworks Inc (ZYME) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8038
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zymeworks Inc (Zymeworks) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of biotherapeutics for the treatment of cancer, autoimmune and inflammatory diseases. Its pipeline products include ZW25 and ZW49, novel bispecific antibodies used for the removal of HER2 protein from the cell surface in patients with gastric, breast, and ovarian cancers. Zymeworks’ proprietary therapeutic platforms and its fully-integrated drug development engine ZymeCAD, provide the compatibility to engineer and develop highly-differentiated protein-based drugs candidates.The company is developing a pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. The company has operations in Canada and the US. Zymeworks is headquartered in Vancouver, British Columbia, Canada.

Zymeworks Inc (ZYME) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zymeworks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zymeworks Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Zymeworks Raises USD61.5 Million in Series A Financing 12
Zymeworks Secures USD23.98 Million in Venture Funding 14
Zymeworks Raises USD4 Million in Venture Financing 15
Zymeworks Raises US$11 Million In Venture Financing 16
Partnerships 17
ImClone Systems Enters Licensing Agreement with Zymeworks 17
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 18
Applied BioMath Extends Partnership with Zymeworks 19
Zymeworks Enters into Agreement with Kairos Therapeutics 20
ProBioGen Enters into Agreement with Zymeworks 21
Zymeworks Enters into Research Agreement with University of California, Los Angeles 22
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 23
Licensing Agreements 24
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 24
Janssen Biotech Enters into Licensing Agreement with Zymeworks 25
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 26
Zymeworks Enters into Licensing Agreement with Daiichi Sankyo 27
Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions 28
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 29
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 30
Zymeworks Enters into Licensing Agreement with Selexis 31
Celgene Exercises Licensing Agreement with Zymeworks for Bi-Specific Antibody 32
Zymeworks Extends Licensing Agreement with Merck 33
Zymeworks Expands Licensing Agreement with Eli Lilly 34
Zymeworks Enters into Licensing with Agreement with Lilly 35
Equity Offering 36
Zymeworks Raises USD97.8 Million in Public Offering of Share 36
Zymeworks Announces Underwriters Exercise of Over-Allotment Option in IPO 38
Zymeworks Raises USD1.8 Million in Private Placement of Shares 40
Zymeworks Raises USD8.6 Million in Private Placement of Shares 41
Zymeworks Completes Private Placement of Shares for USD17.3 Million 42
Acquisition 43
Zymeworks Acquires Remaining 80.01% Stake in Kairos Therapeutics for USD24.8 Million 43
Zymeworks Acquires 19.99% Stake in Kairos Therapeutics for USD3.6 Million 44
Zymeworks Inc – Key Competitors 45
Zymeworks Inc – Key Employees 46
Zymeworks Inc – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 48
Financial Announcements 48
Aug 01, 2018: Zymeworks reports financial results for the second quarter of 2018 48
May 01, 2018: Zymeworks Reports 2018 First Quarter Financial Results 50
Mar 14, 2018: Zymeworks Reports 2017 Year-End Financial Results 51
Nov 08, 2017: Zymeworks Reports Third Quarter 2017 Financial Results and Provides Business Update 52
Aug 08, 2017: Zymeworks Reports Second Quarter 2017 Financial Results 53
May 15, 2017: Zymeworks Reports First Quarter 2017 Financial Results 54
Corporate Communications 55
Sep 19, 2018: Zymeworks appoints Anthony Polverino as executive vice president of early development and Chief Scientific Officer 55
Jun 07, 2018: Zymeworks appoints Ali Tehrani and Nick Bedford as board directors 56
Feb 14, 2017: Zymeworks Appoints Dr. Kenneth Hillan and Hollings Renton to its Board of Directors 57
Product News 58
Jan 05, 2017: Zymeworks Announces the Successful Achievement of a Research Milestone with Lilly in Bispecific Antibody Collaboration 58
Clinical Trials 59
Mar 14, 2018: Zymeworks Advances Clinical Candidate Incorporating Technology from Kairos Acquisition 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
Zymeworks Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zymeworks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zymeworks Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zymeworks Raises USD61.5 Million in Series A Financing 12
Zymeworks Secures USD23.98 Million in Venture Funding 14
Zymeworks Raises USD4 Million in Venture Financing 15
Zymeworks Raises US$11 Million In Venture Financing 16
ImClone Systems Enters Licensing Agreement with Zymeworks 17
Zymeworks Enters into Research Agreement with University of Victoria and BC Cancer Agency 18
Applied BioMath Extends Partnership with Zymeworks 19
Zymeworks Enters into Agreement with Kairos Therapeutics 20
ProBioGen Enters into Agreement with Zymeworks 21
Zymeworks Enters into Research Agreement with University of California, Los Angeles 22
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 23
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 24
Janssen Biotech Enters into Licensing Agreement with Zymeworks 25
Daiichi Sankyo Enters into Licensing Agreement with Zymeworks 26
Zymeworks Enters into Licensing Agreement with Daiichi Sankyo 27
Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions 28
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 29
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 30
Zymeworks Enters into Licensing Agreement with Selexis 31
Celgene Exercises Licensing Agreement with Zymeworks for Bi-Specific Antibody 32
Zymeworks Extends Licensing Agreement with Merck 33
Zymeworks Expands Licensing Agreement with Eli Lilly 34
Zymeworks Enters into Licensing with Agreement with Lilly 35
Zymeworks Raises USD97.8 Million in Public Offering of Share 36
Zymeworks Announces Underwriters Exercise of Over-Allotment Option in IPO 38
Zymeworks Raises USD1.8 Million in Private Placement of Shares 40
Zymeworks Raises USD8.6 Million in Private Placement of Shares 41
Zymeworks Completes Private Placement of Shares for USD17.3 Million 42
Zymeworks Acquires Remaining 80.01% Stake in Kairos Therapeutics for USD24.8 Million 43
Zymeworks Acquires 19.99% Stake in Kairos Therapeutics for USD3.6 Million 44
Zymeworks Inc, Key Competitors 45
Zymeworks Inc, Key Employees 46
Zymeworks Inc, Subsidiaries 47

List of Figures
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zymeworks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Zymeworks Inc (ZYME):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cohort Plc:企業の戦略・SWOT・財務分析
    Cohort Plc - Strategy, SWOT and Corporate Finance Report Summary Cohort Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Owens & Minor Inc (OMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務情報
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Armstrong World Industries Inc (AWI):企業の財務・戦略的SWOT分析
    Armstrong World Industries Inc (AWI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Clydesdale Bank PLC:企業の戦略的SWOT分析
    Clydesdale Bank PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tecnicas Reunidas SA (TRE):企業の財務・戦略的SWOT分析
    Tecnicas Reunidas SA (TRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Canada Energy Partners Inc (CE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. It develops a wellbore mining technology …
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • EndoChoice Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoChoice Inc (EndoChoice), a subsidiary of Boston Scientific Corp is a medical device company that develops and commercializes medical devices, diagnostic equipment, infection control products and endoscopic imaging systems. The company’s infection control products comprise biopsy valves, …
  • Whiting Petroleum Corp (WLL):企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Brother Enterprises Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Brother Enterprises Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Brother Enterprises Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Gerdau S.A.:企業の戦略・SWOT・財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • National Mobile Telecommunications Company K.S.C.P.:企業の戦略・SWOT・財務分析
    National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report Summary National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • Acadia Healthcare Company Inc:企業のM&A・事業提携・投資動向
    Acadia Healthcare Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acadia Healthcare Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Maanshan Iron & Steel Company Limited:企業の戦略・SWOT・財務情報
    Maanshan Iron & Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Maanshan Iron & Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Alitalia – Societa Aerea Italiana S.p.A.:戦略・SWOT・企業財務分析
    Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Tullow Oil Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Tullow Oil Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Tullow Oil Plc (Tullow) is an independent upstream oil and gas company. It explores for, develops and produces oil and natural gas in Africa and South America. The company has licenses, both onshore and o …
  • Steel Dynamics Inc:戦略・SWOT・企業財務分析
    Steel Dynamics Inc - Strategy, SWOT and Corporate Finance Report Summary Steel Dynamics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆